At a glance
ClinicalIndex Comparison RecordN/ACompleted· 50 enrolled
Drug / intervention
Caterpillar™ Arterial Embolization Devicedevice
Likely dose
Not stated in record
Structured eligibility isn't available for this trial yet — see the full criteria in the Eligibility tab below.
Standardized by ClinicalIndex from the ClinicalTrials.gov record · verify against the source.
A Prospective, Multi-Center, Single-Arm, Real World Study Assessing the Clinical Use of the Caterpillar™ Arterial Embolization Device for Arterial Embolization in the Peripheral Vasculature (MONARCH)
In Brief
A clinical study evaluating Caterpillar™ Arterial Embolization Device for Embolization, Therapeutic. Completed, enrolled 50 participants across 11 sites.
Detailed Summary
The primary objective of this study is to evaluate the performance and safety of the Caterpillar™ Arterial Embolization Device when used for arterial embolization in the peripheral vasculature in a real world, on-label application.
Study Details
Study Typeinterventional
Allocation--
Masking--
Primary Purpose--
ConditionsEmbolization, Therapeutic
CountriesUnited States
Collaborators--
Timeline
N/ACompletedFinished
2020202120222023202420252026
First PostedJan 2020
Enrollment StartApr 2020
Primary CompletionAug 2021
Study CompletionAug 2022
TodayJul 2026
First PostedJan 28, 2020
Enrollment StartApr 30, 2020
Primary CompletionAug 13, 2021
Study CompletionAug 12, 2022
TodayJul 2, 2026
Enrollment to primary: 1.3 yearsPosted 6.4 years ago
Interventions
Caterpillar™ Arterial Embolization Devicedevice
Placement of the Caterpillar™ Arterial Embolization Device for patients requiring arterial embolization in the peripheral vasculature.